CD8A and melanoma: In an immune-desert murine model of B16-F10 melanoma, Zander et al. revealed that CD4+ T cell-derived IL-21 can reprogram CD8+ T cells and drive their differentiation into protective cytotoxic CX3CR1+ CD8+ T cells, resulting in a more than two-fold increase in their proportion within the TIME [102].